"Ideally, a single plant could produce enough mRNA to vaccinate a single person," said an associate professor at the University of California, Riverside.
Pharmaceutical giant says its vaccine only "may be" effective in reducing "severe disease and hospitalization," and falls short of confirming protection from infection.
